Hyperparathyroidism in a patient with autoimmune polyglandular syndrome.

Autoimmune hypercalcemia has been reported in only a few cases, and never in the context of autoimmune polyglandular syndrome. A patient with type 1, insulin-dependent diabetes mellitus, Graves' disease, and antiparietal cell antibodies presented with persistent hypercalcemia with inappropriate PTH secretion. Other causes of hypercalcemia were excluded. In this context of two associated organ-specific autoimmune diseases we searched for autoantibodies directed to parathyroid tissue and to calcium-sensing receptor. Anti-parathyroid autoantibodies were detected by indirect immunofluorescence on parathyroid adenomas, and autoantibody against a peptide of the extracellular domain of the calcium-sensing receptor were detected by immunoblotting. Autoimmune hypercalcemia may be another organ-specific feature of autoimmune polyglandular syndrome.

[1]  P. Vestergaard,et al.  Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow‐up study on methods , 2008, Clinical endocrinology.

[2]  L. Peltonen,et al.  Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. , 2008, The New England journal of medicine.

[3]  T. Fujita,et al.  An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations , 2007, Proceedings of the National Academy of Sciences.

[4]  E. Brown,et al.  The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. , 2007, The Journal of clinical endocrinology and metabolism.

[5]  W. Taylor,et al.  Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy , 2007, Diabetes/metabolism research and reviews.

[6]  M. Rubin,et al.  Asymptomatic primary hyperparathyroidism. , 2006, Arquivos brasileiros de endocrinologia e metabologia.

[7]  J. Barker.  Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. , 2006, The Journal of clinical endocrinology and metabolism.

[8]  J. Bilezikian,et al.  Rare causes of hypercalcemia , 2005 .

[9]  H. Vidal,et al.  Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism. , 2004, The Journal of clinical endocrinology and metabolism.

[10]  E. Brown,et al.  Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. , 2004, The New England journal of medicine.

[11]  S. Silverberg,et al.  Clinical practice. Asymptomatic primary hyperparathyroidism. , 2004, The New England journal of medicine.

[12]  R. Thakker.  Diseases associated with the extracellular calcium-sensing receptor. , 2004, Cell calcium.

[13]  E. Brown,et al.  Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. , 2004, The Journal of clinical endocrinology and metabolism.

[14]  J. Garber,et al.  A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. , 2003, The Journal of clinical endocrinology and metabolism.

[15]  J. Rastad,et al.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. , 2002, The Journal of clinical endocrinology and metabolism.

[16]  P. Gonzalo,et al.  Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins. , 1999, Journal of autoimmunity.

[17]  W. Taylor,et al.  Prevalence of Primary Hyperparathyroidism in Patients with Diabetes Mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[18]  Y. Li,et al.  Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. , 1996, The Journal of clinical investigation.

[19]  J. Seidman,et al.  Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 1993, Cell.

[20]  C. Boitard,et al.  Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[21]  J. Seidman,et al.  The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families , 1992, Nature Genetics.